Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
$513M |
| 2 |
Medtronic
MDT
|
$497M |
| 3 |
Apple
AAPL
|
$432M |
| 4 |
L3Harris
LHX
|
$340M |
| 5 |
Danaher
DHR
|
$254M |
Top Sells
| 1 |
Mastercard
MA
|
$427M |
| 2 |
AbbVie
ABBV
|
$387M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
$315M |
| 4 |
CoStar Group
CSGP
|
$270M |
| 5 |
Abbott
ABT
|
$258M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Marvell Technology
MRVL
$54.6B
| $128M | 0.07% |
5,131,779
+2,224,927
| +77% | +$55.6M |
|
302
Graphic Packaging
GPK
$6.38B
| $126M | 0.07% |
8,532,069
-230,710
| -3% | -$3.4M |
|
303
ResMed
RMD
$40.6B
| $126M | 0.07% |
930,797
-65,322
| -7% | -$8.83M |
|
|
GLIBA
304
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $126M | 0.07% |
2,024,410
+557,865
| +38% | +$34.6M |
|
305
AES
AES
$9.21B
| $125M | 0.07% |
7,625,547
+513,622
| +7% | +$8.39M |
|
306
Exxon Mobil
XOM
$466B
| $125M | 0.07% |
1,764,623
-557,351
| -24% | -$39.4M |
|
307
Corpay
CPAY
$22.4B
| $124M | 0.07% |
434,041
-42,730
| -9% | -$12.3M |
|
308
DTE Energy
DTE
$28.4B
| $124M | 0.07% |
1,093,006
-324,648
| -23% | -$36.7M |
|
309
HealthEquity
HQY
$7.88B
| $122M | 0.07% |
2,138,716
+80,885
| +4% | +$4.62M |
|
310
Lamb Weston
LW
$8.08B
| $122M | 0.07% |
1,676,712
+176,573
| +12% | +$12.8M |
|
311
Cintas
CTAS
$82.4B
| $121M | 0.07% |
1,811,964
+338,612
| +23% | +$22.7M |
|
312
Globe Life
GL
$11.3B
| $121M | 0.07% |
1,261,157
-56,823
| -4% | -$5.44M |
|
313
DexCom
DXCM
$31.6B
| $120M | 0.07% |
3,225,264
-777,660
| -19% | -$29M |
|
314
Americold
COLD
$3.98B
| $120M | 0.07% |
3,246,519
+2,405,681
| +286% | +$89.2M |
|
|
GRA
315
DELISTED
W.R. Grace & Co.
GRA
| $120M | 0.06% |
1,793,048
+837,375
| +88% | +$55.9M |
|
316
Keysight
KEYS
$28.9B
| $119M | 0.06% |
1,228,376
+60,936
| +5% | +$5.93M |
|
317
Unifirst Corp
UNF
$3.3B
| $119M | 0.06% |
610,585
-106,724
| -15% | -$20.8M |
|
|
GBT
318
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $119M | 0.06% |
2,449,371
+16,766
| +0.7% | +$813K |
|
319
Xylem
XYL
$34.2B
| $118M | 0.06% |
1,477,994
-39,542
| -3% | -$3.15M |
|
320
Texas Roadhouse
TXRH
$11.2B
| $117M | 0.06% |
2,228,453
-5,624
| -0.3% | -$295K |
|
321
H.B. Fuller
FUL
$3.37B
| $116M | 0.06% |
2,498,092
-345,086
| -12% | -$16.1M |
|
322
Manulife Financial
MFC
$52.1B
| $116M | 0.06% |
6,330,343
+233,709
| +4% | +$4.29M |
|
323
Synopsys
SNPS
$111B
| $116M | 0.06% |
843,939
+122,253
| +17% | +$16.8M |
|
|
RTN
324
DELISTED
Raytheon Company
RTN
| $115M | 0.06% |
585,850
-351,642
| -38% | -$69M |
|
325
Public Service Enterprise Group
PEG
$40.5B
| $114M | 0.06% |
1,839,814
-218,935
| -11% | -$13.6M |
|